About 47 employees are affected, according to Verrica Pharmaceuticals Inc.'s latest layoff filing, on October 1, 2024. As of November 15, 2026, Verrica Pharmaceuticals Inc. has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, October 1, 2024).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Verrica Pharmaceuticals Inc.
Free to see. No signup.
People from Verrica Pharmaceuticals Inc. who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the Verrica Pharmaceuticals Inc. layoff? Add yourself to the open-to-work list, free
Your entry
Verrica Pharmaceuticals Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05, 1 of 1 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Verrica Pharmaceuticals have layoffs in 2024? What its filings say
Verrica Pharmaceuticals Inc. (CIK 1660334) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2024-10-01
Employees affected
On October 1, 2024, Verrica Pharmaceuticals Inc. (the "Company") announced a reduction of its workforce by 47 employees, which the Company expects to be substantially completed by October 1, 2024.
Expected charges
As a result, the Company expects to incur total expenses of approximately $1.0 million, including a one-time charge totaling approximately $0.7 million in connection with one-time employee termination costs, including severance and other benefits, and an estimated deemed loss on vehicle sales of $0.3 million.
Also on the record for Verrica Pharmaceuticals Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 13, 2026 | Stake report, Schedule 13G/A, by Affinity Asset Advisors, LLC | 4.99% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 4.99% of the class | 5%+ stakes | Source |
| January 29, 2026 | Stake report, Schedule 13G/A, by Affinity Asset Advisors, LLC | 5.5% of the class | 5%+ stakes | Source |
| December 30, 2025 | Stake report, Schedule 13D/A, by Caligan Partners LP | 9.99% of the class | 5%+ stakes | Source |
| December 10, 2025 | Form D, private offering | $50.02M sold | Form D page | Source |
| December 3, 2025 | Stake report, Schedule 13G, by Affinity Asset Advisors, LLC | 5.47% of the class | 5%+ stakes | Source |
| November 28, 2025 | Stake report, Schedule 13D/A, by Paul B Manning | 49.9% of the class | 5%+ stakes | Source |
| November 24, 2025 | Stake report, Schedule 13D, by Caligan Partners LP | 9.99% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 6.77% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 9.99% of the class | 5%+ stakes | Source |
Keep reading
More on Verrica Pharmaceuticals Inc. and the records around it.
Verrica Pharmaceuticals Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Form D filing Dec 2025
- Who owns it
Companies that share a holder
- Paul B Manning also filed stake reports on 2 other companies: LIQUIDIA CORP (Aug 2026), CANDEL THERAPEUTICS, INC. (Mar 2026)
- Caligan Partners LP also filed stake reports on 9 other companies: Avalo Therapeutics, Inc. (Aug 2026), Cellectar Biosciences, Inc. (Aug 2026), Faeth Therapeutics, Inc. (Aug 2026)
- Affinity Asset Advisors, LLC also filed stake reports on 16 other companies: Amanat Acquisition Corp. (Nov 2026), Equillium Inc. (Nov 2026), Forte Biosciences, Inc. (Nov 2026)
Watch Verrica Pharmaceuticals Inc.
Get an email when Verrica Pharmaceuticals Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Verrica Pharmaceuticals Inc.?
Want the whole picture on Verrica Pharmaceuticals Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Verrica Pharmaceuticals Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Verrica Pharmaceuticals Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for Verrica Pharmaceuticals Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Who owns Verrica Pharmaceuticals Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/verrica-pharmaceuticals